BSX - Boston Scientific Corporation
| Previous close | 51.48 |
| Open | 51.30 |
| Bid | 51.63 x 1000 |
| Ask | 51.64 x 1300 |
| Day's range | 50.99 - 51.74 |
| 52-week range | 34.98 - 54.17 |
| Volume | |
| Avg. volume | 9,348,668 |
| Market cap | 74.279B |
| Beta (5Y monthly) | 0.80 |
| PE ratio (TTM) | 86.11 |
| EPS (TTM) | 0.60 |
| Earnings date | 25 Jul 2023 - 31 Jul 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 58.40 |
Simply Wall St.Investors Could Be Concerned With Boston Scientific's (NYSE:BSX) Returns On Capital
There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...
ZacksVeeva Systems (VEEV) Extends Tie-Up With Lotus Clinical
Veeva Systems (VEEV) expands its partnership with Lotus Clinical to accelerate clinical trials.
ZacksBoston Scientific (BSX) Rises 26.4%: Will the Rally Continue?
Boston Scientific (BSX) gains from strong improvement in organic sales, indicating a solid rebound in the legacy business.
ZacksIs Augmedix (AUGX) Outperforming Other Medical Stocks This Year?
Here is how Augmedix, Inc. (AUGX) and Boston Scientific (BSX) have performed compared to their sector so far this year.
ZacksCatalent (CTLT) Expands Its Facility Capabilities in Shiga
Catalent's (CTLT) latest capability expansion is expected to boost its business in the global clinical trials space in its Clinical Supply Services network.
- Simply Wall St.
Can Boston Scientific Corporation (NYSE:BSX) Performance Keep Up Given Its Mixed Bag Of Fundamentals?
Boston Scientific's (NYSE:BSX) stock is up by 9.1% over the past three months. However, the company's financials look a...
ZacksWhy Is Boston Scientific (BSX) Down 0.9% Since Last Earnings Report?
Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Veeva Systems (VEEV) Offerings Adopted by Minaris Regenerative
Veeva Systems' (VEEV) Vault Quality Suite applications are expected to aid the CDMO to modernize its operations and streamline its quality processes globally.
ZacksMedtronic (MDT) Q4 Earnings Beat Estimates, Margins Down
Strong growth in the Cardiovascular, Medical Surgical, and Neuroscience portfolios, and in Diabetes markets drove Medtronic (MDT) Q4 revenues.
- Zacks
Masimo's (MASI) Platform Expansion to Boost Patient Monitoring
Masimo's (MASI) latest expansion to its HEOS platform will likely revolutionize health and wellness tracking by allowing connected care as consumers become tetherless and smartphone-less.
ZacksBoston Scientific (BSX) Gains From Acquisitions, New Launches
Boston Scientific (BSX) remains excited about 2023 performance and expects to continue to outpace its peers within the EMEA market.
ZacksAccuray (ARAY) Hits 52-Week High: What's Aiding the Stock?
Investors are optimistic about Accuray's (ARAY) solid product portfolio.
- Zacks
Veeva Systems' (VEEV) New Tie-Up to Improve Clinical Trials
Veeva Systems' (VEEV) latest collaboration is expected to advance the patient experience in clinical trials.
- Simply Wall St.
Boston Scientific Corporation's (NYSE:BSX) Intrinsic Value Is Potentially 20% Below Its Share Price
Key Insights Using the 2 Stage Free Cash Flow to Equity, Boston Scientific fair value estimate is US$41.38 Current...
ZacksAvantor's (AVTR) New Tie-Up to Improve Lab Inventory Management
Avantor's (AVTR) latest partnership is expected to significantly optimize labs' inventory management and the overall workflow.
- Zacks
3 Reasons to Add Merit Medical (MMSI) Stock to Your Portfolio
Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.
Zacks3 Reasons to Hold Inspire Medical (INSP) Stock in Your Portfolio
Investors continue to be optimistic about Inspire Medical (INSP) on the back of its product innovations.
ZacksBD's (BDX) Latest Product Launch to Boost Research Outcome
BD's (BDX) latest cell sorting technology is expected to speed up the process of cell sorting and allow researchers to answer complex biological questions.
ZacksHCA Healthcare (HCA) Gains 29% in a Year: More Upside Left?
HCA Healthcare (HCA) is well-poised for growth on the back of higher revenues, a diversified treatment network and sound operating cash flows.
ZacksAre Medical Stocks Lagging Boston Scientific (BSX) This Year?
Here is how Boston Scientific (BSX) and Aravive (ARAV) have performed compared to their sector so far this year.
- Simply Wall St.
Boston Scientific Insiders Sold US$6.3m Of Shares Suggesting Hesitancy \
Many Boston Scientific Corporation ( NYSE:BSX ) insiders ditched their stock over the past year, which may be of...
ZacksBoston Scientific (BSX) Just Overtook the 20-Day Moving Average
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
ZacksZacks Industry Outlook Highlights Stryker, Boston Scientific, Zimmer Biomet and Insulet
Stryker, Boston Scientific, Zimmer Biomet and Insulet are part of the Zacks Industry Outlook article.
Zacks4 Medical Products Stocks to Capitalize on the Industry's Recovery
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should lend support to the Zacks Medical-Products industry. SYK, BSX, ZBH and PODD are well-poised to gain from the favorable factors.
- Simply Wall St.
Those who invested in Boston Scientific (NYSE:BSX) five years ago are up 72%
Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...
